Found 1 results
Filters: Author is J.Z.S. Chen  [Clear All Filters]
Y. Wu, Wang, B., Li, Y. H., Xu, X. G., Luo, Y. J., Chen, J. Z. S., Wei, H. C., Gao, X. H., and Chen, H. D., Meta-analysis demonstrates association between Arg72Pro polymorphism in the P53 gene and susceptibility to keloids in the Chinese population, vol. 11, pp. 1701-1711, 2012.
Al-Attar A, Mess S, Thomassen JM, Kauffman CL, et al. (2006). Keloid pathogenesis and treatment. Plast. Reconstr. Surg. 117: 286-300. PMid:16404281   Atiyeh BS, Costagliola M and Hayek SN (2005). Keloid or hypertrophic scar: the controversy: review of the literature. Ann. Plast. Surg. 54: 676-680. PMid:15900161   Bayat A, McGrouther DA and Ferguson MW (2003). Skin scarring. BMJ 326: 88-92. PMid:12521975 PMCid:1125033   Butler PD, Longaker MT and Yang GP (2008). Current progress in keloid research and treatment. J. Am. Coll. Surg. 206: 731-741. PMid:18387480   De Felice B, Ciarmiello LF, Mondola P, Damiano S, et al. (2007). Differential p63 and p53 expression in human keloid fibroblasts and hypertrophic scar fibroblasts. DNA Cell Biol. 26: 541-547. PMid:17688405   Higgins JP and Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat. Med. 21: 1539-1558. PMid:12111919   Jin J, Gao JH and Lu F (2007). Clinical experiment of susceptible people to keloid. Zhongguo Lin Chuang Jie Pao Xue Za Zhi 25: 320-322.   Ladin DA, Hou Z, Patel D, McPhail M, et al. (1998). p53 and apoptosis alterations in keloids and keloid fibroblasts. Wound Repair Regen. 6: 28-37. PMid:9776848   Liu Y (2007). Preliminary Linkage Analysis of Keloid Susceptibility Loci and Polymorphisms of Correlation Genes in Chinese Han Population. Master's thesis, China Medical University, Shenyang.   Liu YB (2008). The Study of Impaired Apoptosis Function of Fas and P53 Protein in the Fibroblasts Derived from Keloid. PhD thesis, Southern Medical University, Guangzhou.   Liu YB, Gao JH, Duan HJ and Liu XJ (2003). Investigation of p53 gene mutations in keloids using PCR-SSCP. Zhonghua Zheng Xing Wai Ke Za Zhi 19: 258-260. PMid:14628411   Liu W, Jiang YH, Li YL, Lin ZH, et al. (2004). Experimental study on p53 gene mutation in keloid fibroblasts. Zhonghua Shao Shang Za Zhi 20: 85-87. PMid:15312469   Marneros AG and Krieg T (2004). Keloids-clinical diagnosis, pathogenesis, and treatment options. J. Dtsch. Dermatol. Ges. 2: 905-913. PMid:16281608   Matlashewski GJ, Tuck S, Pim D, Lamb P, et al. (1987). Primary structure polymorphism at amino acid residue 72 of human p53. Mol. Cell Biol. 7: 961-963. PMid:3547088 PMCid:365159   McGregor JM, Harwood CA, Brooks L, Fisher SA, et al. (2002). Relationship between p53 codon 72 polymorphism and susceptibility to sunburn and skin cancer. J. Invest. Dermatol. 119: 84-90. PMid:12164929   Menezes HL, Juca MJ, Gomes EG, Nunes BL, et al. (2010). Analysis of the immunohistochemical expressions of p53, bcl-2 and Ki-67 in colorectal adenocarcinoma and their correlations with the prognostic factors. Arq. Gastroenterol. 47: 141-147. PMid:20721457   Peters JL, Sutton AJ, Jones DR, Abrams KR, et al. (2006). Comparison of two methods to detect publication bias in meta-analysis. JAMA 295: 676-680. PMid:16467236   Pezeshki A, Sari-Aslani F, Ghaderi A and Doroudchi M (2006). p53 codon 72 polymorphism in basal cell carcinoma of the skin. Pathol. Oncol. Res. 12: 29-33. PMid:16554913   Saed GM, Ladin D, Olson J, Han X, et al. (1998). Analysis of p53 gene mutations in keloids using polymerase chain reaction-based single-strand conformational polymorphism and DNA sequencing. Arch. Dermatol. 134: 963-967. PMid:9722726   Sakamuro D, Sabbatini P, White E and Prendergast GC (1997). The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene 15: 887-898. PMid:9285684   Sayah DN, Soo C, Shaw WW, Watson J, et al. (1999). Downregulation of apoptosis-related genes in keloid tissues. J. Surg. Res. 87: 209-216. PMid:10600351   Sjalander A, Birgander R, Kivela A and Beckman G (1995). p53 polymorphisms and haplotypes in different ethnic groups. Hum. Hered. 45: 144-149. PMid:7615299   Tanaka A, Hatoko M, Tada H, Iioka H, et al. (2004). Expression of p53 family in scars. J. Dermatol. Sci. 34: 17-24. PMid:14757278   Teofoli P, Barduagni S, Ribuffo M, Campanella A, et al. (1999). Expression of Bcl-2, p53, c-jun and c-fos protooncogenes in keloids and hypertrophic scars. J. Dermatol. Sci. 22: 31-37.   Thomas M, Kalita A, Labrecque S, Pim D, et al. (1999). Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol. Cell Biol. 19: 1092-1100. PMid:9891044 PMCid:116039   Vandenbroucke JP, von Elm E, Altman DG, Gotzsche PC, et al. (2007). Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology 18: 805-835. PMid:18049195   Walker KK and Levine AJ (1996). Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc. Natl. Acad. Sci. U. S. A. 93: 15335-15340. PMid:8986812 PMCid:26405   Wang CM, Hiko H and Nakazawa N (2005). Investigation of p53 polymorphism for genetic predisposition of keloid and hypertrophic scar. Zhonghua Zheng Xing Wai Ke Za Zhi 21: 32-35. PMid:15844595   Yan L, Lu XY, Wang CM, Cao R, et al. (2007). Association between p53 gene codon 72 polymorphism and keloid in Chinese population. Zhonghua Zheng Xing Wai Ke Za Zhi 23: 428-430. PMid:18161363   Zhuo Y, Gao JH, Luo SQ, Zeng WS, et al. (2005). p53 gene codon 72 polymorphism and susceptibility to keloid. Zhonghua Zheng Xing Wai Ke Za Zhi 21: 201-203. PMid:16128105   Zhuo Y, Gao JH and Zeng XY (2008). The application of P53 gene detection kit for susceptibility of keloid. Zhongguo Mei Rong Yi Xue 5: 694-696.   Zintzaras E and Ioannidis JP (2005). Heterogeneity testing in meta-analysis of genome searches. Genet. Epidemiol. 28: 123-137. PMid:15593093